发明授权
- 专利标题: 17-substituted steroids useful in cancer treatment
- 专利标题(中): 17-取代的类固醇可用于癌症治疗
-
申请号: US315882申请日: 1994-09-30
-
公开(公告)号: US5604213A公开(公告)日: 1997-02-18
- 发明人: Susan E. Barrie , Michael Jarman , Gerard A. Potter , Ian R. Hardcastle
- 申请人: Susan E. Barrie , Michael Jarman , Gerard A. Potter , Ian R. Hardcastle
- 申请人地址: GB2 London
- 专利权人: British Technology Group Limited
- 当前专利权人: British Technology Group Limited
- 当前专利权人地址: GB2 London
- 优先权: GBX9207057 19920331; GBX9224880 19921127; GBX9320132 19930930; GBX9414192 19940714
- 主分类号: C07J13/00
- IPC分类号: C07J13/00 ; C07J31/00 ; C07J41/00 ; C07J43/00 ; C07J51/00 ; A61K31/58
摘要:
Compounds of the general formula (1) ##STR1## wherein X represents the residue of the A, B and C rings of a steroid, R represents a hydrogen atom or an alkyl group of 1 to 4 carbon atoms, R.sup.14 represents a hydrogen atom and R.sup.15 represents a hydrogen atom or an alkyl or alkoxy group of 1-4 carbon atoms, or a hydroxy or alkylcarbonyloxy group of 2 to 5 carbon atoms or R.sup.14 and R.sup.15 together represent a double bond, and R.sup.16 represents a hydrogen atom or an alkyl group of 1 to 4 carbon atoms, in the form of the free bases or phannaceutically acceptable acid addition salts, are useful for treatment of androgen-dependent disorders, especially prostatic cancer, and also oestrogen-dependent disorders such as breast cancer.
公开/授权文献
- US4938298A Directional well control 公开/授权日:1990-07-03
信息查询